APP and Alzheimer disease: Pharmacological inhibition and genetic knock-down of LRP-1 in APP/PS1 mouse model of AD accelerated brain accumulation of Aβ and exacerbated Aβ deposition as amyloid plaques and cerebral amyloid angiopathy without affecting Aβ production (Kanekiyo et al., 2012).